To date, Alzheimer's disease (AD) drug candidates have produced negative results in human trials and progress moving new targets out of the laboratory and into trials has been slow. However, based on three decades of previous work, there is reason to hope that amyloid-based and other novel therapies will move at a faster pace towards successful clinical trials. Here we highlight selected preclinical research topics that are rapidly advancing in the laboratory.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.